Genmab A (GMAB) Total Current Liabilities (2023 - 2025)
Genmab A (GMAB) has disclosed Total Current Liabilities for 2 consecutive years, with $1.4 billion as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Total Current Liabilities rose 91.8% year-over-year to $1.4 billion, compared with a TTM value of $1.4 billion through Dec 2025, up 91.8%, and an annual FY2025 reading of $1.4 billion, up 91.8% over the prior year.
- Total Current Liabilities was $1.4 billion for Q4 2025 at Genmab A, up from $744.0 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $1.4 billion in Q4 2025 and bottomed at $744.0 million in Q4 2024.